The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Novel Germline Mutation of KIT Associated With Familial Gastrointestinal Stromal Tumors and Mastocytosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cause of mastocytosis is mutational hyperactivation of KIT, the tyrosine kinase receptor for stem cell factor, which mast cell development and survival depend on. These mutations are typically somatic, and germline mutations are very rare. 149 , 150 , 151 , 152 , 153 , 154 , 155”
From Mast cell ontogeny: From fetal development to life‐long health and disease (2023) · cites this paper as [152]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Research works printed but not linked: 26
- Kitamura, 2003, Gastrointestinal stromal tumors (GIST), Cancer Sci, 94, 315, 10.1111/j.1349-7006.2003.tb01439.x · DOI
- Duensing, 2004, Biology of gastrointestinal stromal tumors, Cancer Invest, 22, 106, 10.1081/CNV-120027585 · DOI
- Longley, 1996, Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis, Nat Genet, 12, 312, 10.1038/ng0396-312 · DOI
- Longley, 1999, Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis, Proc Natl Acad Sci U S A, 96, 1609, 10.1073/pnas.96.4.1609 · DOI
- Marshall, 1990, Achalasia due to diffuse esophageal leiomyomatosis and inherited as an autosomal dominant disorder. Report of a family study, Gastroenterology, 98, 1358, 10.1016/0016-5085(90)90357-7 · DOI
- Nishida, 1998, Familial gastrointestinal stromal tumours with germline mutation of the KIT gene, Nat Genet, 19, 323, 10.1038/1209 · DOI
- Rosbotham, 1999, Lack of c-kit mutation in familial urticaria pigmentosa, Br J Dermatol, 140, 849, 10.1046/j.1365-2133.1999.02814.x · DOI
- Isozaki, 2000, Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors, Am J Pathol, 157, 1581, 10.1016/S0002-9440(10)64795-5 · DOI
- Hirota, 2000, Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene, Am J Surg Pathol, 24, 326, 10.1097/00000478-200002000-00045 · DOI
- Maeyama, 2001, Familial gastrointestinal stromal tumor with hyperpigmentation, Gastroenterology, 120, 210, 10.1053/gast.2001.20880 · DOI
- Beghini, 2001, Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestional stromal tumors and urticaria pigmentosa, Cancer, 92, 657, 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D · DOI
- Hirota, 2002, Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene, Gastroenterology, 122, 1493, 10.1053/gast.2002.33024 · DOI
- Chompret, 2004, PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor, Gastroenterology, 126, 318, 10.1053/j.gastro.2003.10.079 · DOI
- Tang, 2004, A germline mutation in KIT in familial diffuse cutaneous mastocytosis, J Med Genet, 41, e88, 10.1136/jmg.2003.015156 · DOI · Paper page
- Hirota, 1998, Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors, Science, 279, 577, 10.1126/science.279.5350.577 · DOI
- Ma, 1999, Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region, J Biol Chem, 274, 13399, 10.1074/jbc.274.19.13399 · DOI
- Longley, 2001, Classes of c-KIT activating mutations, Leuk Res, 25, 571, 10.1016/S0145-2126(01)00028-5 · DOI
- Nagata, 1995, Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder, Proc Natl Acad Sci U S A, 92, 10560, 10.1073/pnas.92.23.10560 · DOI
- Joensuu, 2001, Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor, N Engl J Med, 344, 1052, 10.1056/NEJM200104053441404 · DOI
- Ma, 2002, The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations, Blood, 99, 1741, 10.1182/blood.V99.5.1741 · DOI
- Pardanani, 2003, CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy, Blood, 102, 3093, 10.1182/blood-2003-05-1627 · DOI
- Akin, 2004, A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib, Blood, 103, 3222, 10.1182/blood-2003-11-3816 · DOI · Paper page
- Heinrich, 2003, PDGFRA activating mutations in gastrointestinal stromal tumors, Science, 299, 708, 10.1126/science.1079666 · DOI
- Hirota, 2003, Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors, Gastroenterology, 125, 660, 10.1016/S0016-5085(03)01046-1 · DOI
- Hofbauer, 1974, Family with mast cell erythroderma, Hautarzt, 25, 246
- Gari, 1999, C-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia, Br J Haematol, 105, 894, 10.1046/j.1365-2141.1999.01449.x · DOI
Cited by
Sorted by citations
Valent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationBodemer, C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.281 · Cited by 397
Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management
Pardanani, A. (2023) · American Journal of Hematology · doi:10.1002/ajh.26962 · Cited by 132
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis
Berezowska, S., Flaig, M. J., Ruëff, F., Walz, C., Haferlach, T., Krokowski, M., Kerler, R., Petat-Dutter, K., Horny, H.-P., & Sotlar, K. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.117 · Cited by 109
Mast cell ontogeny: From fetal development to life‐long health and disease
Chia, S. L., Kapoor, S., Carvalho, C., Bajénoff, M., & Gentek, R. (2023) · Immunological Reviews · doi:10.1111/imr.13191 · Cited by 60
Metadata
- Authors
- Hartmann, K., Wardelmann, E., Ma, Y., Merkelbach–Bruse, S., Preussner, L. M., Woolery, C., Baldus, S. E., Heinicke, T., Thiele, J., Buettner, R., & Longley, B. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2005-09
- Volume
- 129
- Issue
- 3
- Pages
- 1042-1046
- ISSN
- 0016-5085
- Cited by
- 157
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel Germline Mutation of KIT Associated With Familial Gastrointestinal Stromal Tumors and Mastocytosis. https://app.cochat.ai/papers/10.1053/j.gastro.2005.06.060
- The paper
- Hartmann, K., Wardelmann, E., Ma, Y., Merkelbach–Bruse, S., Preussner, L. M., Woolery, C., Baldus, S. E., Heinicke, T., Thiele, J., Buettner, R., & Longley, B. J. (2005). Novel Germline Mutation of KIT Associated With Familial Gastrointestinal Stromal Tumors and Mastocytosis. Gastroenterology. https://doi.org/10.1053/j.gastro.2005.06.060